Exchange Announcement • 13 May 2026 19:44
Exchange Announcement • 04 May 2026 22:47
Exchange Announcement • 30 Apr 2026 19:09
Exchange Announcement • 29 Apr 2026 20:10
Exchange Announcement • 28 Apr 2026 19:23
𝛼SK or SearchENTITY
Edding Genor Group (6998 HK)
Edding Genor Group (6998 HK)
46
Analysis
Health Care • China
Edding Genor Group is an integrated specialty biopharmaceutical company focused on oncology, autoimmune diseases, cardiovascular diseases, respiratory diseases, and anti-infectives. It discovers, develops, manufactures, and commercializes biopharmaceutical products, primarily through acquiring branded drug assets and licensing patented drugs. The company is headquartered in Shanghai, China, and was founded in 2001.
morex